Invivogen: Ruxolitinib
Lab Reagents
Human IgG antibody Laboratories manufactures the invivogen: ruxolitinib reagents distributed by Genprice. The Invivogen: Ruxolitinib reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact InVivoGen. Other Invivogen: products are available in stock. Specificity: Invivogen: Category: Ruxolitinib
Ruxolitinib (INCB018424) |
|||
A3012-25 | ApexBio | 25 mg | EUR 224 |
Description: Ruxolitinib dihydrochloride is a specific inhibitor of Janus-associated kinase (JAK1 and JAK2). Ruxolitinib is a small molecular with the formula of C17H21N6O4Pand Molecular Weight of 404. |
Ruxolitinib (INCB018424) |
|||
A3012-5 | ApexBio | 5 mg | EUR 131 |
Description: Ruxolitinib dihydrochloride is a specific inhibitor of Janus-associated kinase (JAK1 and JAK2). Ruxolitinib is a small molecular with the formula of C17H21N6O4Pand Molecular Weight of 404. |
Ruxolitinib (INCB018424) |
|||
A3012-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 131 |
Description: Ruxolitinib dihydrochloride is a specific inhibitor of Janus-associated kinase (JAK1 and JAK2). Ruxolitinib is a small molecular with the formula of C17H21N6O4Pand Molecular Weight of 404. |
Ruxolitinib (INCB018424) |
|||
A3012-S | ApexBio | Evaluation Sample | EUR 81 |
Description: Ruxolitinib dihydrochloride is a specific inhibitor of Janus-associated kinase (JAK1 and JAK2). Ruxolitinib is a small molecular with the formula of C17H21N6O4Pand Molecular Weight of 404. |
Ruxolitinib (S enantiomer) |
|||
HY-50856A | MedChemExpress | 5mg | EUR 340 |
S-Ruxolitinib (INCB018424) |
|||
A4149-1 | ApexBio | 1 mg | EUR 231 |
Description: S-Ruxolitinib is the chirality of INCB018424, is a potent and selective small-molecule Janus kinase 1 (JAK1) and JAK2 inhibitor. It was initially developed to target the constitutive activation of the JAK-STAT pathway. |
S-Ruxolitinib (INCB018424) |
|||
A4149-5 | ApexBio | 5 mg | EUR 429 |
Description: S-Ruxolitinib is the chirality of INCB018424, is a potent and selective small-molecule Janus kinase 1 (JAK1) and JAK2 inhibitor. It was initially developed to target the constitutive activation of the JAK-STAT pathway. |
S-Ruxolitinib (INCB018424) |
|||
A4149-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 306 |
Description: S-Ruxolitinib is the chirality of INCB018424, is a potent and selective small-molecule Janus kinase 1 (JAK1) and JAK2 inhibitor. It was initially developed to target the constitutive activation of the JAK-STAT pathway. |
Ruxolitinib, Free base |
|||
2139-100 | Biovision | Ask for price |
Ruxolitinib, Free base |
|||
2139-25 | Biovision | EUR 533 |
Ruxolitinib, Free base |
|||
2139-5 | Biovision | EUR 207 |
Ruxolitinib (JAK kinase inhibitor) |
|||
SIH-509-25MG | Stressmarq | 25 mg | EUR 625 |
|
|||
Description: The substance Ruxolitinib is a jak kinase inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is off-white solid which is soluble in DMSO (25 mg/ml) or EtOH (~15 mg/ml). |
Ruxolitinib (JAK kinase inhibitor) |
|||
SIH-509-5MG | Stressmarq | 5 mg | EUR 238 |
|
|||
Description: The substance Ruxolitinib is a jak kinase inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is off-white solid which is soluble in DMSO (25 mg/ml) or EtOH (~15 mg/ml). |